I have no doubt we will see the B Cell stuff in the next few years treating patients and hopefully in a deal for ongoing rewards.However my question was about whether the OV (oncolytic virus), namely, CF33 would be approved.
Dave made a good point in the timeline aspect and said that they are probably trying to get a safe dosage for PD1 first
A Partnership Deal or Buyout for Imugene?, page-75
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
0.003(6.82%) |
Mkt cap ! $349.6M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.5¢ | $963.9K | 20.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 1558493 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 1495843 | 7 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |